Synopsis: Anondita Medicare Limited has received a purchase order worth Rs. 2.92 crore from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India, for the supply of condoms under the Ustad Nirodh programme. The order is scheduled to be executed over the next four months and strengthens the company’s presence in the public healthcare procurement segment.
Shares of Anondita Medicare Limited are likely to remain in focus after the company announced that it has secured a government purchase order from the Central Medical Services Society (CMSS), an autonomous procurement agency under the Ministry of Health and Family Welfare.
Anondita Medicare Limited has a total market capitalization of approximately Rs. 2,186.76 crore. The company’s shares were trading at Rs. 1209 apiece on the stock exchange, up by 1 percent during the session. The stock has surged around 5.31 percent over the last five trading sessions. The stock has surged around 30.05 percent over the last month, reflecting positive momentum. The stock touched a 52-week high of Rs. 1316 and a 52-week low of Rs. 261.75.
According to the company’s regulatory filing, the order pertains to the supply of Condoms SMO (Ustad Nirodh-HLL) [363] and carries a total contract value of approximately Rs. 2.92 crore. The contract has been awarded by a domestic government entity and will be executed in accordance with the terms and conditions agreed upon under the tender process.
As per the order terms, 50 percent of the total quantity is to be supplied within 60 days from the date of the purchase order, while the remaining 50 percent will be executed between 61 and 120 days. The phased execution schedule provides revenue visibility over the coming quarters.
The latest order highlights Anondita Medicare’s growing participation in India’s public healthcare procurement ecosystem. Government agencies regularly procure contraceptive products under national family planning and public health programmes, creating a stable demand environment for qualified manufacturers.
The Ustad Nirodh programme plays an important role in India’s reproductive health and family welfare initiatives. Orders under such programmes are generally backed by government funding and provide manufacturers with access to large-volume institutional business opportunities.
From an investor perspective, government contracts are viewed positively as they help strengthen order books, improve revenue visibility, and diversify customer bases. The latest order also demonstrates the company’s ability to meet quality and compliance requirements necessary for participation in public-sector healthcare tenders.
India’s healthcare and preventive care market continues to witness steady growth, supported by increasing awareness regarding family planning, rising healthcare spending, and government initiatives aimed at improving access to healthcare products across urban and rural regions.
Founded in March 2024, Anondita Medicare Limited is engaged in the manufacturing of flavored male condoms, with its flagship brand marketed under the name “COBRA”. The company focuses on sexual wellness products and caters to both institutional and consumer markets. The new Rs. 2.92 crore government order could support the company’s revenue growth in the near term while enhancing its credibility as a supplier to public healthcare programmes.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
